Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bush

Showing results (361-370 of 517) with videos related to

Pageof 52
Sort By:
The Journal of Biological Chemistry|August 23, 2002
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2)Carlos Opazo, Xudong Huang, Robert A Cherny, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 17, 2017
Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohortVeer Bala Gupta, Eugene Hone, Steve Pedrini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 3, 2004
Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloidKevin J Barnham, Fredrik Haeffner, Giuseppe D Ciccotosto, et al.
Scientific Reports|October 27, 2017
A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohortSteve Pedrini, Veer B Gupta, Eugene Hone, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 27, 2015
Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor proteinScott Ayton, Peng Lei, Dominic J Hare, et al.
The Journal of Clinical Investigation|August 30, 2005
Alzheimer disease beta-amyloid activity mimics cholesterol oxidaseLuigi Puglielli, Avi L Friedlich, Kenneth D R Setchell, et al.
Acta Neuropathologica Communications|November 16, 2016
Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluidBlaine R Roberts, James D Doecke, Alan Rembach, et al.
Neurobiology of Aging|June 11, 2014
Dietary and lifestyle guidelines for the prevention of Alzheimer's diseaseNeal D Barnard, Ashley I Bush, Antonia Ceccarelli, et al.
Scientific Reports|February 21, 2019
Elevated ubiquitinated proteins in brain and blood of individuals with schizophreniaChad A Bousman, Sandra Luza, Serafino G Mancuso, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's DiseaseSteven H Liang, Adam G Southon, Benjamin H Fraser, et al.
Pageof 52

Showing results (361-370 of 517) with videos related to

Sort By:
Pageof 52
The Journal of Biological Chemistry|August 23, 2002
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2)Carlos Opazo, Xudong Huang, Robert A Cherny, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 17, 2017
Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohortVeer Bala Gupta, Eugene Hone, Steve Pedrini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 3, 2004
Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloidKevin J Barnham, Fredrik Haeffner, Giuseppe D Ciccotosto, et al.
Scientific Reports|October 27, 2017
A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohortSteve Pedrini, Veer B Gupta, Eugene Hone, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 27, 2015
Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor proteinScott Ayton, Peng Lei, Dominic J Hare, et al.
The Journal of Clinical Investigation|August 30, 2005
Alzheimer disease beta-amyloid activity mimics cholesterol oxidaseLuigi Puglielli, Avi L Friedlich, Kenneth D R Setchell, et al.
Acta Neuropathologica Communications|November 16, 2016
Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluidBlaine R Roberts, James D Doecke, Alan Rembach, et al.
Neurobiology of Aging|June 11, 2014
Dietary and lifestyle guidelines for the prevention of Alzheimer's diseaseNeal D Barnard, Ashley I Bush, Antonia Ceccarelli, et al.
Scientific Reports|February 21, 2019
Elevated ubiquitinated proteins in brain and blood of individuals with schizophreniaChad A Bousman, Sandra Luza, Serafino G Mancuso, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's DiseaseSteven H Liang, Adam G Southon, Benjamin H Fraser, et al.
Pageof 52